These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9212778)
1. Disposition of butadiene epoxides in Sprague-Dawley rats. Valentine JL; Boogaard PJ; Sweeney LM; Turner MJ; Bond JA; Medinsky MA Chem Biol Interact; 1997 May; 104(2-3):103-15. PubMed ID: 9212778 [TBL] [Abstract][Full Text] [Related]
2. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Himmelstein MW; Turner MJ; Asgharian B; Bond JA Carcinogenesis; 1994 Aug; 15(8):1479-86. PubMed ID: 8055623 [TBL] [Abstract][Full Text] [Related]
3. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Seaton MJ; Follansbee MH; Bond JA Carcinogenesis; 1995 Oct; 16(10):2287-93. PubMed ID: 7586124 [TBL] [Abstract][Full Text] [Related]
4. Physiologically based pharmacokinetic modeling of 1,3-butadiene, 1,2-epoxy-3-butene, and 1,2:3,4-diepoxybutane toxicokinetics in mice and rats. Sweeney LM; Schlosser PM; Medinsky MA; Bond JA Carcinogenesis; 1997 Apr; 18(4):611-25. PubMed ID: 9111190 [TBL] [Abstract][Full Text] [Related]
5. A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation. Johanson G; Filser JG Arch Toxicol; 1993; 67(3):151-63. PubMed ID: 8494494 [TBL] [Abstract][Full Text] [Related]
6. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Himmelstein MW; Asgharian B; Bond JA Toxicol Appl Pharmacol; 1995 Jun; 132(2):281-8. PubMed ID: 7785055 [TBL] [Abstract][Full Text] [Related]
7. Species difference in the ovarian toxicity of 1,3-butadiene epoxides in B6C3F1 mice and Sprague-Dawley rats. Doerr JK; Hollis EA; Sipes IG Toxicology; 1996 Oct; 113(1-3):128-36. PubMed ID: 8901892 [TBL] [Abstract][Full Text] [Related]
8. Identification of novel metabolites of butadiene monoepoxide in rats and mice. Richardson KA; Peters MM; Megens RH; van Elburg PA; Golding BT; Boogaard PJ; Watson WP; van Sittert NJ Chem Res Toxicol; 1998 Dec; 11(12):1543-55. PubMed ID: 9860500 [TBL] [Abstract][Full Text] [Related]
9. A physiological toxicokinetic model for 1,3-butadiene in rodents and man: blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts--relevance of glutathione depletion. Csanády GA; Kreuzer PE; Baur C; Filser JG Toxicology; 1996 Oct; 113(1-3):300-5. PubMed ID: 8901913 [TBL] [Abstract][Full Text] [Related]
10. Glutathione conjugation of 1,2:3,4- diepoxybutane in human liver and rat and mouse liver and lung in vitro. Boogaard PJ; Sumner SC; Bond JA Toxicol Appl Pharmacol; 1996 Feb; 136(2):307-16. PubMed ID: 8619238 [TBL] [Abstract][Full Text] [Related]
11. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene. Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821 [TBL] [Abstract][Full Text] [Related]
12. Butadiene diolepoxide- and diepoxybutane-derived DNA adducts at N7-guanine: a high occurrence of diolepoxide-derived adducts in mouse lung after 1,3-butadiene exposure. Koivisto P; Kilpeläinen I; Rasanen I; Adler ID; Pacchierotti F; Peltonen K Carcinogenesis; 1999 Jul; 20(7):1253-9. PubMed ID: 10383898 [TBL] [Abstract][Full Text] [Related]
13. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures. Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Csanády GA; Guengerich FP; Bond JA Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680 [TBL] [Abstract][Full Text] [Related]
15. Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace. Bond JA; Recio L; Andjelkovich D Carcinogenesis; 1995 Feb; 16(2):165-71. PubMed ID: 7859344 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of butadiene monoxide by freshly isolated hepatocytes from mice and rats: different partitioning between oxidative, hydrolytic, and conjugation pathways. Kemper RA; Krause RJ; Elfarra AA Drug Metab Dispos; 2001 Jun; 29(6):830-6. PubMed ID: 11353751 [TBL] [Abstract][Full Text] [Related]
17. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach. Motwani HV; Törnqvist M Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046 [TBL] [Abstract][Full Text] [Related]
18. Inhalation pharmacokinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice. Laib RJ; Filser JG; Kreiling R; Vangala RR; Bolt HM Environ Health Perspect; 1990 Jun; 86():57-63. PubMed ID: 2401272 [TBL] [Abstract][Full Text] [Related]
19. A comprehensive structural analysis of hemoglobin adducts formed after in vitro exposure of erythrocytes to butadiene monoxide. Moll TS; Harms AC; Elfarra AA Chem Res Toxicol; 2000 Nov; 13(11):1103-13. PubMed ID: 11087432 [TBL] [Abstract][Full Text] [Related]
20. Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene. Osterman-Golkar SM; Moss O; James A; Bryant MS; Turner M; Bond JA Toxicol Appl Pharmacol; 1998 May; 150(1):166-73. PubMed ID: 9630466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]